Teva Can Market Generic Provigil Three Years Before Patent Expiration
This article was originally published in The Pink Sheet Daily
Executive Summary
Under a settlement with Cephalon, Teva’s modafinil can enter the market in 2011 or 2012, depending on a potential pediatric extension.
You may also be interested in...
Two Down, Two To Go: Cephalon Settles With Ranbaxy Over Provigil Generic
Nearly two weeks after settling with Teva, Cephalon has reached a settlement with Ranbaxy that is identical to Teva's deal for generic modafinil.
Two Down, Two To Go: Cephalon Settles With Ranbaxy Over Provigil Generic
Nearly two weeks after settling with Teva, Cephalon has reached a settlement with Ranbaxy that is identical to Teva's deal for generic modafinil.
Cephalon Expects To Launch Modafinil For ADHD In Early 2006
The company must resolve final Sparlon labeling issues identified in an “approvable” letter.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: